TOPDDRIVE
LIVE

Serial Number

99442152

Owner

Callio Operating Co, Inc.

Attorney

Joyce Liou

Filing Date

Oct 14, 2025

Add to watchlist:

No watchlists yet
View on USPTO

TOPDDRIVE Trademark

Serial Number: 99442152

TOPDDRIVE is a trademark filed by Callio Operating Co, Inc. on October 14, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Callio Operating Co, Inc. (4 trademarks)

1201 3rd Ave, Suite 2200-124
Seattle, WA 98101

Entity Type: 03

Trademark Details

Filing Date

October 14, 2025

Registration Date

Not Registered

Published for Opposition

May 5, 2026

Goods & Services

Research and development in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies, oncology; Providing medical scientific research information in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies, oncology, and immunology; Drug discovery, custom design, and development services featuring therapeutic agents for the treatment and prevention of diseases; Scientific investigations for medical purposes featuring clinical trials

Custom manufacturing of pharmaceuticals and therapeutic agents for medical use

Pharmaceutical and biological preparations for the treatment of cancer; Pharmaceuticals and biological preparations for prophylactic, diagnostic, and therapeutic use in treating, preventing, and managing cancer; Therapeutic agents for medical use, namely, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies; Pharmaceutical and biological preparations for the prevention, diagnosis and treatment of diseases for scientific, clinical, medicinal, therapeutic and diagnostic purposes; Pharmaceutical and biological preparations for use in oncology

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 5, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 5, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 29, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 8, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 7, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 7, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 7, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 20, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 20, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 20, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 3, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Oct 14, 2025 MAFR
NEW APPLICATION ENTERED
Oct 14, 2025 NWAP